Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2018

Feb 21, 2018

29875_dirs_2018-02-21_ee3f1716-f1b7-4295-8fe5-c2140339ea2a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2018-02-16

Reporting Person: Foulkes Helena (EVP & President-CVS Pharmacy)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-16 Common Stock M 19965 $45.07 Acquired 65072.3477 Direct
2018-02-16 Common Stock S 19965 $71.04 Disposed 45107.3477 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-16 Stock Option $45.07 M 19965 Disposed 2019-04-02 Common Stock (19965) Direct

Footnotes

F1: Option became exercisable in four equal annual installments, commencing 4/2/2013.